141 related articles for article (PubMed ID: 12185406)
1. Bupropion occupancy of the dopamine transporter is low during clinical treatment.
Meyer JH; Goulding VS; Wilson AA; Hussey D; Christensen BK; Houle S
Psychopharmacology (Berl); 2002 Aug; 163(1):102-5. PubMed ID: 12185406
[TBL] [Abstract][Full Text] [Related]
2. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
[TBL] [Abstract][Full Text] [Related]
4. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.
Argyelán M; Szabó Z; Kanyó B; Tanács A; Kovács Z; Janka Z; Pávics L
J Affect Disord; 2005 Dec; 89(1-3):115-23. PubMed ID: 16213028
[TBL] [Abstract][Full Text] [Related]
6. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
7. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
8. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
10. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.
Damaj MI; Carroll FI; Eaton JB; Navarro HA; Blough BE; Mirza S; Lukas RJ; Martin BR
Mol Pharmacol; 2004 Sep; 66(3):675-82. PubMed ID: 15322260
[TBL] [Abstract][Full Text] [Related]
12. The interaction between dopamine transporter function, gender differences, and possible laterality in depression.
Hsiao MC; Lin KJ; Liu CY; Schatz DB
Psychiatry Res; 2013 Jan; 211(1):72-7. PubMed ID: 23036826
[TBL] [Abstract][Full Text] [Related]
13. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
[TBL] [Abstract][Full Text] [Related]
14. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter density may be associated with the depressed affect in healthy subjects.
Newberg A; Amsterdam J; Shults J
Nucl Med Commun; 2007 Jan; 28(1):3-6. PubMed ID: 17159542
[TBL] [Abstract][Full Text] [Related]
16. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography.
Learned-Coughlin SM; Bergström M; Savitcheva I; Ascher J; Schmith VD; Långstrom B
Biol Psychiatry; 2003 Oct; 54(8):800-5. PubMed ID: 14550679
[TBL] [Abstract][Full Text] [Related]
17. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
19. Lower dopamine transporter binding potential in striatum during depression.
Meyer JH; Krüger S; Wilson AA; Christensen BK; Goulding VS; Schaffer A; Minifie C; Houle S; Hussey D; Kennedy SH
Neuroreport; 2001 Dec; 12(18):4121-5. PubMed ID: 11742250
[TBL] [Abstract][Full Text] [Related]
20. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
Peña S; Baccichet E; Urbina M; Carreira I; Lima L
Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
